INTELLIGENT BIO SOLUTIONS INC. (INBS)

Data as of Mar 20, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch INBS

See up to 3 months of INBS. The 7-day demo opens the 1M and 3M ranges and puts INBS on your watchlist.

Latest INBS insider trades

Steven Constantine Boyages - Director
Grant or award5,000 sh
Mar 18, 2026
Nicola Marion Fraser - Director
Grant or award5,000 sh
Mar 18, 2026
Spiro Kevin Sakiris - Officer
Grant or award

About INTELLIGENT BIO SOLUTIONS INC. (INBS)

INTELLIGENT BIO SOLUTIONS INC. files with the SEC under CIK 0001725430 and is classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.

Sector: Health Care

SEC filings for INBS on EDGAR

INBS Form 4 activity by transaction type, last 90 days

No Form 4 activity for INBS in the last 90 days.

INBS insider transactions (Form 4)

6 Form 4 filings on record, the earliest from Mar 20, 2026, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Mar 18, 2026	Steven Constantine Boyages - Director	Grant or award	Common Stock	5,000^{footnote F2}	$0.00	-
Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until… Full note on SEC EDGAR
Mar 18, 2026	Nicola Marion Fraser - Director	Grant or award	Common Stock	5,000^{footnote F2}	$0.00	-
Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until… Full note on SEC EDGAR
Mar 18, 2026	Spiro Kevin Sakiris - Officer	Grant or award	Common Stock	9,150^{footnote F2}	$0.00	-
Mar 18, 2026	Spiro Kevin Sakiris - Officer	Grant or award	Common Stock	21,350^{footnote F3}	$0.00	-
Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 9,150 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan ("2019 Plan"). The awarded shares are subject to time-based vesting after 48 months and are subject to… Full note on SEC EDGAR Footnote F3 (shares): On March 18, 2026, the Issuer granted the reporting person 21,350 restricted shares of Common Stock under the 2019 Plan. The awarded shares are subject to joint performance-based and time-based vesting requirements and are subject to forfeiture until vested.
Mar 18, 2026	Jonathan Scott Hurd - Director	Grant or award	Common Stock	5,000^{footnote F2}	$0.00	-
Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until… Full note on SEC EDGAR
Mar 18, 2026	Jason Isenberg - Director	Grant or award	Common Stock	5,000^{footnote F2}	$0.00	-
Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until… Full note on SEC EDGAR
Mar 18, 2026	Harry Simeonidis - Officer	Grant or award	Common Stock	9,150^{footnote F2}	$0.00	-
Mar 18, 2026	Harry Simeonidis - Officer	Grant or award	Common Stock	21,350^{footnote F3}	$0.00	-
Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 9,150 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan ("2019 Plan"). The awarded shares are subject to time-based vesting after 48 months and are subject to… Full note on SEC EDGAR Footnote F3 (shares): On March 18, 2026, the Issuer granted the reporting person 21,350 restricted shares of Common Stock under the 2019 Plan. The awarded shares are subject to joint performance-based and time-based vesting requirements and are subject to forfeiture until vested.

Recent INBS Form 8-K filings

Read INBS company news

Oct 13, 2026Item 5.03, 7.01, 9.01

Read the filing on SEC EDGAR

Sep 11, 2026Item 8.01

Read the filing on SEC EDGAR

Sep 9, 2026Item 7.01, 8.01, 9.01

Read the filing on SEC EDGAR

Sep 2, 2026Item 1.01, 3.02, 7.01, 9.01

INBS insider trading FAQ

What is the latest insider trade for INBS?

INTELLIGENT BIO SOLUTIONS INC. (INBS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-20. The full record for INBS runs to 6 Form 4 filings, the earliest from 2026-03-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying INBS stock?

No insider purchases of INBS were filed in the last 90 days.

How many insiders are selling INBS stock?

No insider sales of INBS were filed in the last 90 days.

Where can I see INBS SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects INBS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Mar 20, 2026 - Steven Constantine Boyages view on EDGAR
Mar 20, 2026 - Nicola Marion Fraser view on EDGAR
Mar 20, 2026 - Spiro Kevin Sakiris view on EDGAR
Mar 20, 2026 - Jonathan Scott Hurd view on EDGAR
Mar 20, 2026 - Jason Isenberg view on EDGAR
Mar 20, 2026 - Harry Simeonidis view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Health Care: Where INBS's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow INBS with a 7-day demo

INBS on your watchlist
Every INBS Form 4 filing on record
Up to 3 months of INBS price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Date

Insider

Transaction

Security

Price

Value

Mar 18, 2026

Steven Constantine Boyages - Director

Grant or award

Common Stock

5,000^{footnote F2}

$0.00

Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until… Full note on SEC EDGAR

Mar 18, 2026

Nicola Marion Fraser - Director

Grant or award

Common Stock

5,000^{footnote F2}

$0.00

Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until… Full note on SEC EDGAR

Mar 18, 2026

Spiro Kevin Sakiris - Officer

Grant or award

Common Stock

9,150^{footnote F2}

$0.00

Mar 18, 2026

Spiro Kevin Sakiris - Officer

Grant or award

Common Stock

21,350^{footnote F3}

$0.00

Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 9,150 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan ("2019 Plan"). The awarded shares are subject to time-based vesting after 48 months and are subject to… Full note on SEC EDGAR
Footnote F3 (shares): On March 18, 2026, the Issuer granted the reporting person 21,350 restricted shares of Common Stock under the 2019 Plan. The awarded shares are subject to joint performance-based and time-based vesting requirements and are subject to forfeiture until vested.

Mar 18, 2026

Jonathan Scott Hurd - Director

Grant or award

Common Stock

5,000^{footnote F2}

$0.00

Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until… Full note on SEC EDGAR

Mar 18, 2026

Jason Isenberg - Director

Grant or award

Common Stock

5,000^{footnote F2}

$0.00

Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 5,000 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. The awarded shares are subject to time-based vesting after 12 months and are subject to forfeiture until… Full note on SEC EDGAR

Mar 18, 2026

Harry Simeonidis - Officer

Grant or award

Common Stock

9,150^{footnote F2}

$0.00

Mar 18, 2026

Harry Simeonidis - Officer

Grant or award

Common Stock

21,350^{footnote F3}

$0.00

Footnote F2 (shares): On March 18, 2026, the Issuer granted the reporting person 9,150 restricted shares of Common Stock under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan ("2019 Plan"). The awarded shares are subject to time-based vesting after 48 months and are subject to… Full note on SEC EDGAR
Footnote F3 (shares): On March 18, 2026, the Issuer granted the reporting person 21,350 restricted shares of Common Stock under the 2019 Plan. The awarded shares are subject to joint performance-based and time-based vesting requirements and are subject to forfeiture until vested.